IDH2 and astrocytoma (excluding glioblastoma): Moreover, these tumours often contain additional areas of astrocytic differentiation and display a typical immunohistochemical profile of IDH-mutant astrocytoma, with loss of nuclear ATRX expression, nuclear accumulation of p53, and positive staining for IDH R132H in the vast majority of tumours.